Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

2 May 2013 07:00

RNS Number : 8051D
Sopheon PLC
02 May 2013
 



Thursday 2 May 2013

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

INTERIM MANAGEMENT STATEMENT AND CAPITAL REORGANISATION

 

Sopheon plc, the internationalprovider of software and services that improve the financial return from innovation and product development investments, announces its first interim management statement for the period from1 January 2013 to the date of this announcement.

 

Building on 2012's strong performance, revenue visibility for the 2013 full year from contracted business and recurring revenue streams stands at £7.4 million, compared to £6.5 million a year ago. In addition to the maintenance base and some early license wins, much of the visibility relates to ongoing service projects; the first quarter saw a lot of activity with new license opportunities from a mix of new and existing customers, which we are now starting to close during the second quarter.

 

We have continued our recruitment efforts and since the start of the year have added staff in a number of areas, most notably in our European marketing team. This continues our steady expansion of commercial resources in the territory over the last year. Nevertheless we continue to watch revenue performance very closely, given that global markets continue to lack consistency and prediction of the timing and value of individual sales remains challenging.

 

A major product milestone was achieved with the release of Accolade® 8.2, the latest version of our flagship software solution. With this release, businesses are able, for the first time, to access "a single source of the truth" from a fully-integrated solution across the entire innovation management and new product development lifecycle. New features have been added in a range of areas including Portfolio Management, Innovation Planning and Resource Planning. In addition, support has been extended for project teams, extended search and classification, mass import functionality, international languages, and more efficient IT installation, operations, integration and maintenance capabilities. Further details of this milestone release are described in our announcements of 23 January 2013.

 

Capital Reorganisation

 

Notice of Sopheon's forthcoming Annual General Meeting, to be held at the offices of Squire Sanders (UK) LLP, 7 Devonshire Square, London EC2M 4YH at 11:00am on 12 June 2013 is now available on the Sopheon website, along with a circular that describes proposals for a capital reorganisation, to be put to shareholders in a general meeting of the Company to be held immediately after the Annual General Meeting. 

 

As we have previously stated, the goals of the restructuring include consolidating the number of shares, and reducing the accumulated deficit on the profit and loss account. To that end, the Company is proposing a 10000:1 share consolidation that creates Interim Ordinary Shares of £500 each, followed by a subdivision of 1:500 that creates subdivided ordinary shares of £1 each, and finally a re-designation to reduce the nominal value of the resultant ordinary shares to 20p per New Ordinary Share. The Company is also seeking approval to undertake a capital reduction in order to reduce the deficit on its profit and loss account.

 

The proposed timetable for the reorganisation is given below. Due to differences in the settlement mechanisms between the Netherlands and the UK, the record date set out in the proposed timetable for shares in the Netherlands is three days later than in the UK. This is the reason for the one week gap between the Share Consolidation and the Share Subdivision. Notwithstanding the foregoing, trading in the Interim Ordinary Shares will commence on both AIM and Alternext on 17 June 2013, and trading in the New Ordinary Shares will commence on both AIM and Alternext on 24 June 2013.

 

Full details of the proposed reorganisation, including definitions of capitalised terms not defined in this announcement, can be found in the circular.

 

 

Latest time and date for receipt of Proxy Forms

11.30 a.m. on 10 June 2013

General Meeting

11.30am on 12 June 2013

UK Record Date for the Share Consolidation

5.00 p.m. on 14 June 2013

Existing Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 14 June 2013

Admission effective and dealings commence on AIM and Alternext in Interim Ordinary Shares of £500 each

8.00 a.m. on 17 June 2013

CREST accounts credited with Interim Ordinary Shares

17 June 2013

Netherlands Record Date for Share Consolidation

19 June 2013

UK Record Date for Share Subdivision

5.00 p.m. on 21 June 2013

Interim Ordinary Shares disabled in CREST and share register closed

5.00 p.m. on 21 June 2013

Admission effective and dealings in New Ordinary Shares commence on AIM and Alternext in New Ordinary Shares of 20p each

8.00 a.m. 24 June 2013

CREST accounts credited with New Ordinary Shares

24 June 2013

Netherlands Record Date for Share Subdivision

26 June 2013

New Share certificates dispatched on or before

1 July 2013

Anticipated date for Reduction of Capital - not later than

31 December 2013

 

 

Accolade® is a registered trademark of Sopheon plc.

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Performance solutions including software, expertise, and best-practices to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade® solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle. For the first time, businesses can access a single source of the truth across strategic innovation planning, roadmapping, idea and concept development, process and project management, and portfolio and in-market management. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Alternext Exchange in the Netherlands. For more information, please visit www.sopheon.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKSFEDXDEFF
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.